Delivery Order SPE2DB24D9155-SPE2DB25FHZGW
- Not listed
- The Defense Logistics Agency awarded a $41,661.60 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for 52 mg Mirena systems, effective September 11, 2025, with an ultimate completion date of October 2, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation to supply this contraceptive implant device. This delivery order is issued under DMS Pharmaceutical Group's larger...
- The Defense Logistics Agency awarded a $6,249.24 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, a hormonal contraceptive implant device. The award, issued on September 2, 2025, with an ultimate completion date of September 23, 2025, represents a delivery order under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA valued at $500 million through November 2026. This delivery order does not include a set-aside designation, and the...
- The Defense Logistics Agency awarded a delivery order valued at $5,207.70 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems, a contraceptive implant device. This firm fixed-price delivery order, issued on July 3, 2025, with an ultimate completion date of July 25, 2025, represents a continuation of ongoing pharmaceutical supply services to federal healthcare facilities. The order was placed under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the...
- The Defense Logistics Agency awarded a delivery order valued at $2,603.85 to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, a contraceptive implant product. The contract, issued on August 5, 2025, with an ultimate completion date of August 26, 2025, utilizes firm fixed-price pricing and carries no set-aside designation. The place of performance is Park Ridge, Illinois, where DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is headquartered. This...
- The Defense Logistics Agency awarded a delivery order valued at $5,207.70 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems, a contraceptive implant device. The contract, issued on September 5, 2025, with an ultimate completion date of September 26, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work...
- The Defense Logistics Agency awarded a delivery order valued at $5,207.70 to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, with an ultimate completion date of October 3, 2025. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected through firm fixed-price contracting without a set-aside designation. The delivery order falls under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA...
- The Defense Logistics Agency awarded a delivery order valued at $5,207.70 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems, a contraceptive implant device. Issued on August 20, 2025, with completion targeted for September 11, 2025, this firm fixed-price delivery order represents a standard pharmaceutical supply transaction under the agency's medical procurement operations. The award was made without a set-aside designation, allowing DMS Pharmaceutical Group to compete...
- The Defense Logistics Agency awarded a delivery order valued at $1,562.31 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems, contraceptive implant devices used in military and federal healthcare facilities. The order, issued on June 16, 2025, with an ultimate completion date of July 9, 2025, represents a firm fixed-price delivery under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA. No set-aside designation was used for this award, allowing the...
- The Defense Logistics Agency awarded a $5,207.70 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, with an ultimate completion date of September 3, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order represents a specific product requisition issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $12,498.48 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, a contraceptive implant device. The delivery order, issued on September 9, 2025, with an ultimate completion date of September 30, 2025, represents a single procurement action under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA valued at $500 million through November 2026. The order will be fulfilled from the contractor's...
- SPE2DB24D9155Indefinite Delivery Contract
- SPE2DB24D9155-SPE2DB25FHZGWDelivery Order
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $2,603.85 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems, a contraceptive implant device. The contract, issued on June 6, 2025, with an ultimate completion date of June 30, 2025, carries no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery from its Illinois location. This delivery order represents a task order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a significant vehicle valued at approximately $500 million through November 2026. DMS Pharmaceutical Group has established itself as a key supplier within the federal pharmaceutical supply chain, providing prescription drugs, biologics, and medical consumables to Department of Defense healthcare facilities. The company's extensive contract portfolio with the Defense Logistics Agency demonstrates its capability to reliably deliver diverse pharmaceutical products, from contraceptive devices to specialty medications and vaccines, supporting military health facilities worldwide. This delivery order for Mirena systems reflects the company's ongoing role in furnishing essential medical supplies to federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 6/6/25 |